Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

B.M.J. Uitdehaag; C. Constantinescu; P. Cornelisse; D. Jeffery; L. Kappos; D. Li; M. Sandberg-Wollheim; A. Traboulsee; E. Verdun; V. Rivera

doi:10.1177/1756285610391693

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

B.M.J. Uitdehaag, C. Constantinescu, P. Cornelisse, D. Jeffery, L. Kappos, D. Li, M. Sandberg-Wollheim, A. Traboulsee, E. Verdun, V. Rivera

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	3-14
Journal	Therapeutic Advances in Neurological Disorders
Volume	4
Issue number	1
DOIs	https://doi.org/10.1177/1756285610391693
Publication status	Published - 2011

Access to Document

10.1177/1756285610391693

Cite this

Uitdehaag, B. M. J., Constantinescu, C., Cornelisse, P., Jeffery, D., Kappos, L., Li, D., Sandberg-Wollheim, M., Traboulsee, A., Verdun, E., & Rivera, V. (2011). Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study. Therapeutic Advances in Neurological Disorders, 4(1), 3-14. https://doi.org/10.1177/1756285610391693

Uitdehaag, B.M.J. ; Constantinescu, C. ; Cornelisse, P. ; Jeffery, D. ; Kappos, L. ; Li, D. ; Sandberg-Wollheim, M. ; Traboulsee, A. ; Verdun, E. ; Rivera, V. / Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study. In: Therapeutic Advances in Neurological Disorders. 2011 ; Vol. 4, No. 1. pp. 3-14.

@article{e83e8c1e5cd5423ab48c1d408a250cc8,

title = "Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study",

author = "B.M.J. Uitdehaag and C. Constantinescu and P. Cornelisse and D. Jeffery and L. Kappos and D. Li and M. Sandberg-Wollheim and A. Traboulsee and E. Verdun and V. Rivera",

year = "2011",

doi = "10.1177/1756285610391693",

language = "Undefined/Unknown",

volume = "4",

pages = "3--14",

journal = "Therapeutic Advances in Neurological Disorders",

issn = "1756-2856",

publisher = "SAGE Publications Ltd",

number = "1",

}

Uitdehaag, BMJ, Constantinescu, C, Cornelisse, P, Jeffery, D, Kappos, L, Li, D, Sandberg-Wollheim, M, Traboulsee, A, Verdun, E & Rivera, V 2011, 'Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study', Therapeutic Advances in Neurological Disorders, vol. 4, no. 1, pp. 3-14. https://doi.org/10.1177/1756285610391693

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study. / Uitdehaag, B.M.J.; Constantinescu, C.; Cornelisse, P.; Jeffery, D.; Kappos, L.; Li, D.; Sandberg-Wollheim, M.; Traboulsee, A.; Verdun, E.; Rivera, V.

In: Therapeutic Advances in Neurological Disorders, Vol. 4, No. 1, 2011, p. 3-14.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

AU - Uitdehaag, B.M.J.

AU - Constantinescu, C.

AU - Cornelisse, P.

AU - Jeffery, D.

AU - Kappos, L.

AU - Li, D.

AU - Sandberg-Wollheim, M.

AU - Traboulsee, A.

AU - Verdun, E.

AU - Rivera, V.

PY - 2011

Y1 - 2011

U2 - 10.1177/1756285610391693

DO - 10.1177/1756285610391693

M3 - Article

C2 - 21339904

VL - 4

SP - 3

EP - 14

JO - Therapeutic Advances in Neurological Disorders

JF - Therapeutic Advances in Neurological Disorders

SN - 1756-2856

IS - 1

ER -